1Biller BM,Luciano A,Crosignani PG,et al.Guidelines for the diagnosis and treatment of hyperprolactinemia.J Reprod Med,1999,44(12 Suppl):1075-1084.
2Biller BMK,Daniels GH.Neuroendocrine regulation and diseases of the anterior pituitary and hypothalamus.//Harrison's Principles of Internal Medicine 14th eds.New York:McGraw Hill,1998:1972-1999.
4Casanueva FF,Molitch ME,Schlechte JA,et al.Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas.Clin Endocrinol,2006,65:265-273.
5Franks S,Murray MA,Jequier AM,et al.Incidence and signilicance of hyperprolactinaemia in women with amenorrhea.Clin Endocrinol,1975,4:597-607.
6Greer ME,Moraczewski T,Rakoff JS.Prevalence of hyperprolactinemia in anovulatory women.Obstet Gynecol,1980,56:65-69.
7Jacobs HS,Hull MG,Murray MA,et al.Therapy-orientated diagnosis of secondary amenorrhoea.Horm Res,1975,6:268-287.
8Josimovich JB,Lavenhar MA,Devanesan MM,et al.Heterogeneous distribution of serum prolactin values in apparentiy healthy young women,and the effects of oral contraceptive medication.Fertil Steril,1987,47:785-791.
6L,Abbate A. Large and micro coronary vascular involvement indiabetes[J]. Pharmacol Rep,2005 ,57(Suppl) :3-9.
7WHO. WHO call for interest for development of HbAi c testssuitable for low and middle income countries [EB/OL]. [2012-09-20]. http://www. who. int/diabetes action online/diabetes/basics/en/indexl. html.
8Misra M. SGLT2 inhibitors: a promising new therapeuticoption for treatment of type 2 diabetes mellitus[J]. J PharmPharmacol,201365(3). 317-327.
9Bailey CJ,Gross JL, Pieters A, et al. Effect of dapagliflozin inpatients with type 2 diabetes who have inadequate glycaemiccontrol with metformin: a randomised, double-blind, placebo-controlled trial[J], Lancet.2010,375(9733) :2223-2233.
10Bolinder J, Ljunggren 0,Kullber g J,et al. Effects ofdapagliflozin on body weight,total fat mass,and regionaladipose tissue distribution in patients with type 2 diabetesmellitus with inadequate glycemic control on metformin[J]. JClin Endocrinol Metab,2012,97(3) :1020-1031.
